Chelsie Derman

Subcutaneous anifrolumab for SLE met its primary BICLA endpoint at 52 weeks and significantly increased DORIS-defined remission and low disease activity.

Six weeks of freshly squeezed lemon juice diluted in water significantly reduced serum urate and improved kidney function in patients with gout and hyperuricemia.

Patients with gout frequently experience kinesiophobia and central sensitization, which were independently linked to greater pain intensity.

New research shows both left and bilateral taVNS are safe, noninvasive treatment options that relieve pain in individuals with fibromyalgia.

A large prospective cohort study showed that moderate dietary diversity, particularly greater intake of grains, dairy, vegetables, and fruits, is linked to reduced gout risk.

New data links chronic pain to impaired muscle relaxation, with the greatest limitations observed in fibromyalgia and chronic tension-type headache.

Evidence shows fibromyalgia patients face higher overactive bladder rates and symptom severity, highlighting the importance of integrated care.

Multicenter study shows patients with both CKD and gout achieve better urate control on febuxostat than those with gout alone, despite the lower doses.

A 20-year population study found unilateral adrenalectomy raises long-term risks of CKD and gout in primary aldosteronism.

A study shows that knowledge of hyperuricemia alone doesn’t drive practice. Attitude significantly mediates self-management, particularly in asymptomatic individuals.

Nearly a third of patients with lupus in APPEAL reported falls, with disease activity, depressive symptoms, and medication use among key risk factors.

DRESS-PS extension study shows patients maintaining low disease activity while gradually reducing TNF inhibitor doses over 24 months.

Sarilumab 200 mg every 2 weeks with a 14-week glucocorticoid taper significantly boosted patient-reported outcomes versus placebo in polymyalgia rheumatica.

Virtual cognitive behavioral therapy delivered via phone or online led to moderate improvements in pain and function in the phase 3 RESOLVE trial.

A study of approximately 1.2 million children found no evidence that early exposure to aluminum from vaccines increases the risk of autoimmune, allergic, or neurodevelopmental conditions.

A new study reveals that gout significantly affects hand function, with manual dexterity impairments nearly as severe as those seen in rheumatoid arthritis.

Presented at SDPA, the FOREMOST Trial showed apremilast reduces joint burden and improves function in early oligo PsA through week 48.

Somatization syndromes and childhood trauma emerged as key predictors of fibromyalgia over rheumatoid arthritis in a recent study comparing both groups.

New findings suggest the 2016 criteria may underdiagnose fibromyalgia in patients with comorbidities, potentially missing the disorder’s full clinical complexity.

A study found frequent comorbidity between cluster headache, fibromyalgia, and migraine, as well as heightened depression and sleep disturbance among these individuals.

A recent study identified the prevalence of asymptomatic pulmonary involvement in patients with newly diagnosed RA or PsA, highlighting the need to reevaluate screening protocols.

The exploratory MIRROR trial found pegloticase with methotrexate improved clinical assessment and quality of life outcomes in uncontrolled gout.

The COSMOS trial showed guselkumab every 8 weeks improved PsA outcomes through week 48, including in patients with inadequate responses to TNF inhibitors.

A study found the association between sedentary behavior and gout remained strong even when adjusting for physical activity.

The FDA has accepted the NDA for TNX-102 SL, a non-opioid, centrally acting analgesic, for the bedtime treatment of fibromyalgia; the PDUFA date still needs to be assigned.

At ACR, HCPLive spoke with Erin Treemarcki on a survey that showed many rheumatologists do not use established enthesitis scoring measures for children.

At ACR, HCPLive spoke with Ashima Makol, MD, about factors linked to a worse health-related quality of life in patients with early systemic sclerosis.

Secukinumab is best for severe skin involvement, while adalimumab improves synovitis in PsA. Both are effective, but larger studies are needed for long-term outcomes.

A new study finds visceral adipose tissue and subcutaneous adipose tissue are linked to chronic musculoskeletal pain in both sexes but have a stronger association in females.

Fragility fractures occur every minute in France, totaling 500,000 annually. A report calls for expanding fracture liaison services to address the growing osteoporosis burden.